This inventor holds 1 USPTO granted patent. Top assignees: Children's Hospital, The United States of America, as Represented by the Secretary, Department of Health and Human Services, University of California. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:



Years Active: 2019
Title: Klaus Joachin Van Leyen: Innovator in Lipoxygenase Inhibition
Introduction
Klaus Joachin Van Leyen is a notable inventor based in Medford, MA (US). He has made significant contributions to the field of biochemistry, particularly in the development of inhibitors for human 12/15-lipoxygenase. His work has implications for various medical conditions, showcasing the potential of his inventions in therapeutic applications.
Latest Patents
Klaus Joachin Van Leyen holds 1 patent related to his research on inhibitors of human 12/15-lipoxygenase. This patent describes a systematic screening that has identified a family of compounds exhibiting inhibitory effects on this enzyme. The invention is particularly relevant for treating conditions such as stroke, periventricular leukomalacia, cardiac arrest with resuscitation, atherosclerosis, Parkinson's disease, Alzheimer's disease, and breast cancer.
Career Highlights
Throughout his career, Klaus has worked with prestigious institutions, including Children's Hospital and the University of California. His research has contributed to a deeper understanding of the biochemical pathways involved in various diseases, paving the way for innovative treatment options.
Collaborations
Klaus has collaborated with notable colleagues such as Theodore Holman and David Joseph Maloney. These partnerships have enhanced the scope and impact of his research, fostering advancements in the field of medical science.
Conclusion
Klaus Joachin Van Leyen's work in developing inhibitors for human 12/15-lipoxygenase represents a significant advancement in medical research. His contributions have the potential to lead to new treatments for serious health conditions, highlighting the importance of innovation in the field of biochemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile